Medical Device Collaboration and Licensing Deals 2016-2025: Comprehensive Listing of 903 Deals Including Financial Terms – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Medical Device Collaboration and Licensing Deals 2016-2025” has been added to ResearchAndMarkets.com’s... Read more.
Chai Discovery Announces $130 Million Series B To Transform Molecular Discovery
SAN FRANCISCO–(BUSINESS WIRE)–Chai Discovery, the AI company that predicts and reprograms the interactions between biochemical molecules, today announced... Read more.
NUBURU Secures $25 Million Financing, Advancing Integrated Defense & Security Platform
Transaction with YA II PN, Ltd. enables accelerated execution of NUBURU’s multi-asset defense and security platform targeting $20B+ addressable global markets... Read more.
Madison River Capital Appoints Bob Barthelmes as Operating Advisor and Board Member of JDC Power Systems
Addition of experienced technology executive to enhance operations across MRC portfolio and strengthen JDC Power Systems NEW YORK–(BUSINESS WIRE)–Madison... Read more.
Accord Announces Banking Facility Update and Proposed Debenture Amendments
TORONTO–(BUSINESS WIRE)–Accord Financial Corp. (“Accord” or the “Company”) (TSX – ACD) today announced that it has reached an agreement with... Read more.
ICE Launches TTF Daily Options and Announces Record Trading Across TTF and JKM Natural Gas
AMSTERDAM & LONDON–(BUSINESS WIRE)–Intercontinental Exchange, Inc. (NYSE:ICE), a leading global provider of technology and data and home to the largest... Read more.
Algia Pharma Gains FDA Support to Advance Novel Non-Opioid Pain Treatment Toward a Phase 2 Clinical Trial After IND-Enabling Studies With Indication Expanded to All Mild-to-Moderate Acute Pain
Algia Pharma’s novel multimodal pain regimen, AlgiaPak®, designed to deliver opioid-level pain relief without addiction risk Positive feedback from FDA suggests... Read more.
Zoetis Announces Proposed $1.75 Billion Convertible Senior Notes Offering
Substantially All Net Proceeds Expected to Be Used to Repurchase Common Stock and for Capped Call Transactions PARSIPPANY, N.J.–(BUSINESS WIRE)–$ZTS... Read more.
NeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
NeoGenomics moving toward a full U.S. clinical launch of its RaDaR ST molecular residual disease (MRD) assay in Q1 2026 FORT MYERS, Fla.–(BUSINESS WIRE)–NeoGenomics,... Read more.
Aviceda Therapeutics Announces Phase 2b SIGLEC Results for AVD-104 in Geographic Atrophy
SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular... Read more.